Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
630.58
622.00
609.29
578.66
568.25
594.00
564.69
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
630.58
622.00
609.29
578.66
568.25
594.00
564.69
Raw Material Cost
1.17
1.20
1.28
0.00
0.00
0.00
0.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
93.72
94.17
79.56
68.67
65.26
66.00
66.51
Selling and Distribution Expenses
158.32
158.80
118.22
272.30
110.70
68.00
56.72
Other Expenses
-5.39
-4.32
-2.91
23.18
-1.48
-6.50
-6.60
Total Expenditure (Excl Depreciation)
199.28
211.00
170.00
572.80
161.21
69.00
57.22
Operating Profit (PBDIT) excl Other Income
431.3
411
439.3
5.8999999999999995
407
525
507.5
Other Income
25.79
2.90
21.28
9.48
14.67
78.45
26.26
Operating Profit (PBDIT)
659.44
392.10
449.71
219.28
548.85
439.45
761.33
Interest
93.72
94.17
79.56
68.67
65.26
66.00
66.51
Exceptional Items
-96.29
58.80
75.34
-59.97
-50.16
-39.45
111.53
Gross Profit (PBDT)
629.40
620.80
608.01
0.00
0.00
0.00
0.00
Depreciation
1.17
1.20
1.28
0.00
0.00
0.00
0.00
Profit Before Tax
468.26
356.00
444.21
90.64
433.43
334.00
806.36
Tax
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
294.69
214.00
288.22
30.18
238.35
208.00
543.99
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
294.69
214.00
288.22
30.18
238.35
208.00
543.99
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
173.57
142.00
155.99
60.46
195.08
126.00
262.37
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
468.26
356.00
444.21
90.64
433.43
334.00
806.36
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
6,888.55
6,476.90
6,414.35
6,347.91
6,688.65
6,946.58
6,869.88
Earnings per share (EPS)
0.67
0.5
0.67
0.07
0.55
0.47
1.21
Diluted Earnings per share
0.67
0.5
0.67
0.07
0.55
0.47
1.21
Operating Profit Margin (Excl OI)
100.3%
62.38%
70.11%
36.26%
94.01%
60.77%
130.17%
Gross Profit Margin
74.44%
57.43%
73.12%
15.66%
76.28%
56.23%
142.8%
PAT Margin
46.73%
34.41%
47.3%
5.21%
41.94%
35.02%
96.33%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Mar 2026 is 1.38% vs 2.08% in Dec 2025
Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is 31.54% vs -19.86% in Dec 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Mar 2026 is 62.82% vs -9.15% in Dec 2025
Interest
QoQ Growth in quarter ended Mar 2026 is -0.53% vs 18.34% in Dec 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
Compare Quarterly Results Of Royalty Pharma Plc With
Figures in Million
Consolidate Quarterly Results
Change(USD)
Change(%)
Net Sales
630.58
3,520.30
-2,889.72
-82.09%
Other Operating Income
0.00
0.00
0.00
Total Operating income
630.58
3,520.30
-2,889.72
-82.09%
Raw Material Cost
1.17
2,139.20
-2,138.03
-99.95%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
93.72
120.90
-27.18
-22.48%
Selling and Distribution Expenses
158.32
789.10
-630.78
-79.94%
Other Expenses
-5.39
12.43
-17.82
-143.36%
Total Expenditure (Excl Depreciation)
199.28
3,173.50
-2,974.22
-93.72%
Operating Profit (PBDIT) excl Other Income
431.30
346.80
84.50
24.37%
Other Income
25.79
-20.20
45.99
227.67%
Operating Profit (PBDIT)
659.44
1,002.70
-343.26
-34.23%
Interest
93.72
120.90
-27.18
-22.48%
Exceptional Items
-96.29
-453.00
356.71
78.74%
Gross Profit (PBDT)
629.40
1,381.10
-751.70
-54.43%
Depreciation
1.17
676.10
-674.93
-99.83%
Profit Before Tax
468.26
-247.30
715.56
289.35%
Tax
0.00
-423.70
423.70
100.00%
Provisions and contingencies
0
0
0.00
Profit After Tax
294.69
176.40
118.29
67.06%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
294.69
176.40
118.29
67.06%
Share in Profit of Associates
0
0
0.00
Minority Interest
173.57
0.00
173.57
Other related items
0.00
0.00
0.00
Consolidated Net Profit
468.26
176.40
291.86
165.45%
Equity Capital
0
0
0.00
Face Value
0.00
0.01
0.00
Reserves
6,888.55
14,657.70
-7,769.15
-53.00%
Earnings per share (EPS)
0.67
0.15
0.52
346.67%
Diluted Earnings per share
0.67
0.15
0.52
346.67%
Operating Profit Margin (Excl OI)
100.30%
9.85%
0.00
90.45%
Gross Profit Margin
74.44%
12.18%
0.00
62.26%
PAT Margin
46.73%
5.01%
0.00
41.72%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 63.06 Million
in Mar 2026Figures in Million
QoQ Growth in quarter ended Mar 2026 is 1.38% vs 2.08% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 10.98% vs 0.04% in Mar 2025
Quarterly - Consolidate Net Profit
Consolidate Net Profit 46.83 Million
in Mar 2026Figures in Million
QoQ Growth in quarter ended Mar 2026 is 31.54% vs -19.86% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 8.05% vs 10,179.07% in Mar 2025
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 63.37 Million
in Mar 2026Figures in Million
QoQ Growth in quarter ended Mar 2026 is 62.82% vs -9.15% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 18.63% vs 823.85% in Mar 2025
Quarterly - Interest
Interest 9.37 Million
in Mar 2026Figures in Million
QoQ Growth in quarter ended Mar 2026 is -0.53% vs 18.34% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 43.49% vs 47.74% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 100.30%
in Mar 2026Figures in %
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
